Himalaya-The Podcast Player

4.8K Ratings
Open In App
title

Speaking of SurgOnc

Annals of Surgical Oncology and Society of Surgical Oncology

1
Followers
0
Plays
Speaking of SurgOnc

Speaking of SurgOnc

Annals of Surgical Oncology and Society of Surgical Oncology

1
Followers
0
Plays
OVERVIEWEPISODESYOU MAY ALSO LIKE

Details

About Us

"Speaking of SurgOnc" is a podcast series brought to you by the Annals of Surgical Oncology (ASO) and the Society of Surgical Oncology(SSO). Dr. Frederick L. (Rick) Greene, ASO Deputy Editor, will explore and expand upon ideas and concepts described in articles published in the Annals of Surgical Oncology. Dr. Greene will interview authors and leading experts about topics of current importance in surgical oncology.

Latest Episodes

Complex General Surgical Oncology Fellowship Applicants: Trends over Time and the Impact of Board Certification Eligibility

Rick Greene, MD and Elizabeth Grubbs, MD, MS discuss an analysis of the applicant pool of complex general surgical oncology (CGSO) fellowships and how it has changed over the last decade. Dr. Grubbs is Associate Professor, Program Director of Complex General Surgical Oncology Fellowship, Vice Chair of Education, Department of Surgical Oncology, Division of Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX.

7 MIN3 w ago
Comments
Complex General Surgical Oncology Fellowship Applicants: Trends over Time and the Impact of Board Certification Eligibility

Symptom burden at the end-of-life for neuroendocrine tumors: an analysis of 2,579 prospectively collected patient-reported outcomes

Rick Greene, MD and Julie Hallet, MD discuss the moderate-to-severe symptoms observed to steeply increase as death nears for patients with neuroendocrine tumors (NETs), which highlight an opportunity for improved management. Dr. Hallet is Assistant Professor, Surgical Oncology, University of Toronto and Sunnybrook Health Sciences Centre, Toronto, Canada.

7 MINMAY 12
Comments
Symptom burden at the end-of-life for neuroendocrine tumors: an analysis of 2,579 prospectively collected patient-reported outcomes

Germline Genetic Testing: What the Breast Surgeon Needs to Know

Dr. Greene and Dr. Plichta discuss the potential benefit for women from genetic testing for BRCA1, BRCA2, and other breast cancer genes and the knowledge needed by breast surgeons to facilitate testing and counseling. Dr. Plichta is author of, “Germline Genetic Testing: What the Breast Surgeon Needs to Know.” Dr. Plichta is an Assistant Professor of Surgery, Division of Surgical Oncology, Duke Surgery, Duke University School of Medicine, Durham, NC.

7 MINAPR 7
Comments
Germline Genetic Testing: What the Breast Surgeon Needs to Know

Maintenance of Certification and Continuing Medical Education: Are They Still Required?

Rick Greene, MD and Marissa M. Howard-McNatt, MD discuss how the requirements for maintenance of certification (MOC) and CME changed in 2018, and review the options for completing these requisites. Mariss M. Howard-McNatt, MD is author of, “Maintenance of Certification and Continuing Medical Education: Are They Still Required?” Marissa M. Howard-McNatt, MD is an Associate Professor of Surgery Sciences – Oncology, Wake Forest School of Medicine, Winston-Salem, NC.

5 MINMAR 10
Comments
Maintenance of Certification and Continuing Medical Education: Are They Still Required?

Young Women with Breast Cancer: Fertility Preservation Options and Management of Pregnancy-Associated Breast Cancer

Dr. Greene and Dr. Jeruss discuss the potential impact of treatment on the future fertility of young breast cancer patients and review guidelines provided to address reproductive health in conjunction with a breast cancer diagnosis. Dr. Jeruss is an Associate Professor of Surgery at Departments of Surgery, Pathology, and Biomedical Engineering, University of Michigan, Ann Arbor, MI. She specializes in the care of patients with benign and malignant breast disease.

10 MINFEB 11
Comments
Young Women with Breast Cancer: Fertility Preservation Options and Management of Pregnancy-Associated Breast Cancer

Intraoperative Fluorescent Angiography Predicts Pharyngocutaneous Fistula After Salvage Laryngectomy

Dr. Rick Greene and Dr. Andrew J. Rosko discuss how intraoperative usage of indocyanine green imaging can predict the formation of post-operative fistulas, allowing for more tailored reconstructive options depending on risk of fistula. Dr. Rosko is author of, “Intraoperative Fluorescent Angiography Predicts Pharyngocutaneous Fistula After Salvage Laryngectomy.”

7 MINJAN 22
Comments
Intraoperative Fluorescent Angiography Predicts Pharyngocutaneous Fistula After Salvage Laryngectomy

Adjuvant and Neoadjuvant Therapy, Treatment for Advanced Disease, and Genetic Considerations for Adrenocortical Carcinoma: An Update from the SSO Endocrine and Head and Neck Disease Site Working Group

Dr. Rick Greene and Dr. Paxton Dickson discuss adrenocortical carcinoma and related issues regarding adjuvant and neoadjuvant therapy, treatment of advanced disease, and genetic considerations for patients who have this disease. Dr. Dickson serves as an associate professor of surgery at the University of Tennessee Health Science Center and a surgical oncologist for UT Methodist Physicians.

9 MIN2019 DEC 10
Comments
Adjuvant and Neoadjuvant Therapy, Treatment for Advanced Disease, and Genetic Considerations for Adrenocortical Carcinoma: An Update from the SSO Endocrine and Head and Neck Disease Site Working Group

Modified Frailty Index Predicts Morbidity and Mortality After Pancreaticoduodenectomy

Dr. Greene and Dr. Clancy Clark discuss the use of a modified frailty index as a predictor in pancreaticoduodenectomy, its association with postoperative morbidity and mortality, and how it can aid in preoperative risk stratification. Dr. Clark is author of, “Modified Frailty Index Predicts Morbidity and Mortality After Pancreaticoduodenectomy.” Dr. Clark is an Assistant Professor, Department of Surgery, at Wake Forest Baptist Health in Winston-Salem, NC.

10 MIN2019 NOV 13
Comments
Modified Frailty Index Predicts Morbidity and Mortality After Pancreaticoduodenectomy

Impact of Chemoradiation-to-Surgery Interval on Pathological Complete Response and Short- and Long-Term Overall Survival in Esophageal Cancer Patients

Dr. Rick Greene and Dr. Basem Azab discuss the relationship of the interval between neoadjuvant chemoradiation-to-surgery in the treatment of esophageal cancer, and associated pathological complete response rate and overall survival rate. Dr. Azab is a surgical oncology specialist at Sentara Healthcare, Newport News, VA. His clinical expertise includes but is not limited to Esophageal Cancer, Endocrine Tumors, Gastrointestinal Oncology, Hepatobiliary Tumors.

9 MIN2019 OCT 8
Comments
Impact of Chemoradiation-to-Surgery Interval on Pathological Complete Response and Short- and Long-Term Overall Survival in Esophageal Cancer Patients

8th Edition of the AJCC Cancer Staging Manual: Pancreas and Hepatobiliary Cancers

Dr. Greene and Dr. Pawlik discuss the 8th edition of the TNM staging system for pancreas and hepatobiliary cancers, which affirms that the anatomic extent of disease remains the strongest predictor of outcome in hepatobiliary cancers. Dr. Pawlik is ASO Deputy Editor and Editorial Board Section Editor, Hepatobiliary Tumors. He is co-author with Yun Shin Chun and Jean-Nicolas Vauthey of the ASO TNM staging editorial, "8th Edition of the AJCC Cancer Staging Manual: Pancreas and Hepatobiliary Cancers."

7 MIN2019 SEP 10
Comments
8th Edition of the AJCC Cancer Staging Manual: Pancreas and Hepatobiliary Cancers

Latest Episodes

Complex General Surgical Oncology Fellowship Applicants: Trends over Time and the Impact of Board Certification Eligibility

Rick Greene, MD and Elizabeth Grubbs, MD, MS discuss an analysis of the applicant pool of complex general surgical oncology (CGSO) fellowships and how it has changed over the last decade. Dr. Grubbs is Associate Professor, Program Director of Complex General Surgical Oncology Fellowship, Vice Chair of Education, Department of Surgical Oncology, Division of Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX.

7 MIN3 w ago
Comments
Complex General Surgical Oncology Fellowship Applicants: Trends over Time and the Impact of Board Certification Eligibility

Symptom burden at the end-of-life for neuroendocrine tumors: an analysis of 2,579 prospectively collected patient-reported outcomes

Rick Greene, MD and Julie Hallet, MD discuss the moderate-to-severe symptoms observed to steeply increase as death nears for patients with neuroendocrine tumors (NETs), which highlight an opportunity for improved management. Dr. Hallet is Assistant Professor, Surgical Oncology, University of Toronto and Sunnybrook Health Sciences Centre, Toronto, Canada.

7 MINMAY 12
Comments
Symptom burden at the end-of-life for neuroendocrine tumors: an analysis of 2,579 prospectively collected patient-reported outcomes

Germline Genetic Testing: What the Breast Surgeon Needs to Know

Dr. Greene and Dr. Plichta discuss the potential benefit for women from genetic testing for BRCA1, BRCA2, and other breast cancer genes and the knowledge needed by breast surgeons to facilitate testing and counseling. Dr. Plichta is author of, “Germline Genetic Testing: What the Breast Surgeon Needs to Know.” Dr. Plichta is an Assistant Professor of Surgery, Division of Surgical Oncology, Duke Surgery, Duke University School of Medicine, Durham, NC.

7 MINAPR 7
Comments
Germline Genetic Testing: What the Breast Surgeon Needs to Know

Maintenance of Certification and Continuing Medical Education: Are They Still Required?

Rick Greene, MD and Marissa M. Howard-McNatt, MD discuss how the requirements for maintenance of certification (MOC) and CME changed in 2018, and review the options for completing these requisites. Mariss M. Howard-McNatt, MD is author of, “Maintenance of Certification and Continuing Medical Education: Are They Still Required?” Marissa M. Howard-McNatt, MD is an Associate Professor of Surgery Sciences – Oncology, Wake Forest School of Medicine, Winston-Salem, NC.

5 MINMAR 10
Comments
Maintenance of Certification and Continuing Medical Education: Are They Still Required?

Young Women with Breast Cancer: Fertility Preservation Options and Management of Pregnancy-Associated Breast Cancer

Dr. Greene and Dr. Jeruss discuss the potential impact of treatment on the future fertility of young breast cancer patients and review guidelines provided to address reproductive health in conjunction with a breast cancer diagnosis. Dr. Jeruss is an Associate Professor of Surgery at Departments of Surgery, Pathology, and Biomedical Engineering, University of Michigan, Ann Arbor, MI. She specializes in the care of patients with benign and malignant breast disease.

10 MINFEB 11
Comments
Young Women with Breast Cancer: Fertility Preservation Options and Management of Pregnancy-Associated Breast Cancer

Intraoperative Fluorescent Angiography Predicts Pharyngocutaneous Fistula After Salvage Laryngectomy

Dr. Rick Greene and Dr. Andrew J. Rosko discuss how intraoperative usage of indocyanine green imaging can predict the formation of post-operative fistulas, allowing for more tailored reconstructive options depending on risk of fistula. Dr. Rosko is author of, “Intraoperative Fluorescent Angiography Predicts Pharyngocutaneous Fistula After Salvage Laryngectomy.”

7 MINJAN 22
Comments
Intraoperative Fluorescent Angiography Predicts Pharyngocutaneous Fistula After Salvage Laryngectomy

Adjuvant and Neoadjuvant Therapy, Treatment for Advanced Disease, and Genetic Considerations for Adrenocortical Carcinoma: An Update from the SSO Endocrine and Head and Neck Disease Site Working Group

Dr. Rick Greene and Dr. Paxton Dickson discuss adrenocortical carcinoma and related issues regarding adjuvant and neoadjuvant therapy, treatment of advanced disease, and genetic considerations for patients who have this disease. Dr. Dickson serves as an associate professor of surgery at the University of Tennessee Health Science Center and a surgical oncologist for UT Methodist Physicians.

9 MIN2019 DEC 10
Comments
Adjuvant and Neoadjuvant Therapy, Treatment for Advanced Disease, and Genetic Considerations for Adrenocortical Carcinoma: An Update from the SSO Endocrine and Head and Neck Disease Site Working Group

Modified Frailty Index Predicts Morbidity and Mortality After Pancreaticoduodenectomy

Dr. Greene and Dr. Clancy Clark discuss the use of a modified frailty index as a predictor in pancreaticoduodenectomy, its association with postoperative morbidity and mortality, and how it can aid in preoperative risk stratification. Dr. Clark is author of, “Modified Frailty Index Predicts Morbidity and Mortality After Pancreaticoduodenectomy.” Dr. Clark is an Assistant Professor, Department of Surgery, at Wake Forest Baptist Health in Winston-Salem, NC.

10 MIN2019 NOV 13
Comments
Modified Frailty Index Predicts Morbidity and Mortality After Pancreaticoduodenectomy

Impact of Chemoradiation-to-Surgery Interval on Pathological Complete Response and Short- and Long-Term Overall Survival in Esophageal Cancer Patients

Dr. Rick Greene and Dr. Basem Azab discuss the relationship of the interval between neoadjuvant chemoradiation-to-surgery in the treatment of esophageal cancer, and associated pathological complete response rate and overall survival rate. Dr. Azab is a surgical oncology specialist at Sentara Healthcare, Newport News, VA. His clinical expertise includes but is not limited to Esophageal Cancer, Endocrine Tumors, Gastrointestinal Oncology, Hepatobiliary Tumors.

9 MIN2019 OCT 8
Comments
Impact of Chemoradiation-to-Surgery Interval on Pathological Complete Response and Short- and Long-Term Overall Survival in Esophageal Cancer Patients

8th Edition of the AJCC Cancer Staging Manual: Pancreas and Hepatobiliary Cancers

Dr. Greene and Dr. Pawlik discuss the 8th edition of the TNM staging system for pancreas and hepatobiliary cancers, which affirms that the anatomic extent of disease remains the strongest predictor of outcome in hepatobiliary cancers. Dr. Pawlik is ASO Deputy Editor and Editorial Board Section Editor, Hepatobiliary Tumors. He is co-author with Yun Shin Chun and Jean-Nicolas Vauthey of the ASO TNM staging editorial, "8th Edition of the AJCC Cancer Staging Manual: Pancreas and Hepatobiliary Cancers."

7 MIN2019 SEP 10
Comments
8th Edition of the AJCC Cancer Staging Manual: Pancreas and Hepatobiliary Cancers
hmly
Welcome to Himalaya LearningDozens of podcourses featuring over 100 experts are waiting for you.